Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Regenerative Medical Technology (RMTG) Current Deferred Revenue (2021 - 2025)

Historic Current Deferred Revenue for Regenerative Medical Technology (RMTG) over the last 5 years, with Q3 2025 value amounting to $172146.0.

  • Regenerative Medical Technology's Current Deferred Revenue rose 11558.67% to $172146.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $172146.0, marking a year-over-year increase of 11558.67%. This contributed to the annual value of $55684.0 for FY2024, which is 268420.0% up from last year.
  • Per Regenerative Medical Technology's latest filing, its Current Deferred Revenue stood at $172146.0 for Q3 2025, which was up 11558.67% from $121770.0 recorded in Q2 2025.
  • Regenerative Medical Technology's Current Deferred Revenue's 5-year high stood at $372860.0 during Q2 2024, with a 5-year trough of $500.0 in Q2 2023.
  • Over the past 5 years, Regenerative Medical Technology's median Current Deferred Revenue value was $35816.0 (recorded in 2025), while the average stood at $77398.4.
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first plummeted by 8086.12% in 2023, then skyrocketed by 7447200.0% in 2024.
  • Over the past 5 years, Regenerative Medical Technology's Current Deferred Revenue (Quarter) stood at $18215.0 in 2021, then crashed by 42.63% to $10450.0 in 2022, then tumbled by 80.86% to $2000.0 in 2023, then surged by 2684.2% to $55684.0 in 2024, then surged by 209.15% to $172146.0 in 2025.
  • Its last three reported values are $172146.0 in Q3 2025, $121770.0 for Q2 2025, and $35816.0 during Q1 2025.